Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer

[1]  M. Dimopoulos,et al.  Neoadjuvant chemotherapy in invasive bladder cancer , 2005, Expert review of anticancer therapy.

[2]  Nicholas J Vogelzang,et al.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.

[3]  C. Vale.  Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis , 2003, The Lancet.

[4]  N. James,et al.  Organ preservation strategies in bladder cancer , 2002, Expert review of anticancer therapy.

[5]  J. Dunst,et al.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Zietman,et al.  Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. , 2002, Urology.

[7]  P. Dahm,et al.  Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. , 2002, European urology.

[8]  C. Rödel,et al.  Invasive bladder cancer: organ preservation by radiochemotherapy. , 2002, Frontiers of radiation therapy and oncology.

[9]  A. Zietman,et al.  Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. , 2001, Urology.

[10]  N. James,et al.  A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  P. Cooke,et al.  Long–Term Risk of Salvage Cystectomy after Radiotherapy for Muscle–Invasive Bladder Cancer , 2000, European Urology.

[12]  P. Bassi,et al.  Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. , 1999, The Journal of urology.

[13]  R. Sauer,et al.  Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. , 1998, International journal of radiation oncology, biology, physics.

[14]  J. Paradelo,et al.  Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study. , 1997, The Journal of urology.

[15]  J. Cooper,et al.  Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  S. Rockwell,et al.  Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  I. Tannock,et al.  Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Anthony,et al.  Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer , 1996, Annals of Internal Medicine.

[19]  R. James.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin , 1996, The Lancet.

[20]  R. Huddart,et al.  Management of invasive bladder cancer. , 1996, British journal of hospital medicine.

[21]  C. Dinney,et al.  Radical cystectomy for stage T3b bladder cancer. , 1996, Seminars in urologic oncology.

[22]  D. Stewart,et al.  A phase II study of 5-fluorouracil and high dose folinic acid in cisplatin-refractory metastatic bladder cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  A. Zietman,et al.  The combination of cis-platin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. , 1993, International journal of radiation oncology, biology, physics.

[24]  A. Wong,et al.  Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. , 1993, International journal of radiation oncology, biology, physics.

[25]  C. Logothetis,et al.  Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumors. , 1991, Journal of the National Cancer Institute.

[26]  M. Rotman,et al.  Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion. , 1990, International journal of radiation oncology, biology, physics.

[27]  W. Shipley,et al.  Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. , 1985, The Journal of urology.

[28]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .